Drugs / Folic acid (FA)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT04062656 Background | Sep 2019 → Mar 2024 | gastric cancer, gastroesophageal junction adenocarcinoma | University Hospital, Essen | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Folic acid (FA) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04062656 ↗ |
| Route | Intravenous | “Folic acid 200mg/m² IV over 30 min” NCT04062656 ↗ |